Biogen Plans to Buy Early-Stage Alzheimer’s and Parkinson’s Treatment From Pfizer

Biogen has agreed to buy an experimental Alzheimer’s and Parkinson’s treatment from Pfizer, the company announced Monday. In the agreed deal, Biogen will pay…